Management of hemorrhage in gastrointestinal stromal tumors: a review

References

• MiettinenMLasotaJGastrointestinal stromal tumors: pathology and prognosis at different sitesSemin Diagn Pathol200623708317193820
   PubMed Web of Science ®Google Scholar
• LankeGLeeJHHow best to manage gastrointestinal stromal tumorWorld J Clin Oncol2017813514428439494
   PubMedGoogle Scholar
• MiettinenMMajidiMLasotaJPathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a reviewEur J Cancer200238Suppl 5S39S51
   PubMedGoogle Scholar
• PovedaAGarcía Del MuroXLópez-GuerreroJAGEIS guidelines for gastrointestinal sarcomas (GIST)Cancer Treat Rev20175510711928351781
   PubMed Web of Science ®Google Scholar
• CarneyJAGastric stromal sarcoma, pulmonary chondroma, and extra-adrenal paraganglioma (Carney Triad): natural history, adrenocortical component, and possible familial occurrenceMayo Clin Proc19997454355210377927
   PubMed Web of Science ®Google Scholar
• TakazawaYSakuraiSSakumaYGastrointestinal stromal tumors of neurofibromatosis type I (von Recklinghausen’s disease)Am J Surg Pathol20052975576315897742
   PubMed Web of Science ®Google Scholar
• JiangZXZhangSJPengWJYuBHRectal gastrointestinal stromal tumors: imaging features with clinical and pathological correlationWorld J Gastroenterol2013193108311623716991
   PubMed Web of Science ®Google Scholar
• RammohanASathyanesanJRajendranKA gist of gastrointestinal stromal tumors: a reviewWorld J Gastrointest Oncol2013510211223847717
   PubMed Web of Science ®Google Scholar
• NilssonBBümmingPMeis-KindblomJMGastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era–a population-based study in western SwedenCancer200510382182915648083
   PubMed Web of Science ®Google Scholar
• KramerKKnippschildUMayerBImpact of age and gender on tumor related prognosis in gastrointestinal stromal tumors (GIST)BMC Cancer2015155725886494
   PubMed Web of Science ®Google Scholar
• ConlonKCCasperESBrennanMFPrimary gastrointestinal sarcomas: analysis of prognostic variablesAnn Surg Oncol1995226317834450
   PubMed Web of Science ®Google Scholar
• StilesZERistTMDicksonPVImpact of body mass index on the short-term outcomes of resected gastrointestinal stromal tumorsJ Surg Res201721712313028595816
   PubMed Web of Science ®Google Scholar
• von MehrenMRandallRLBenjaminRSSoft tissue sarcoma, version 22016, NCCN clinical practice guidelines in oncologyJ Natl Compr Canc Netw201614675878627283169
   PubMed Web of Science ®Google Scholar
• DemetriGDvon MehrenMAntonescuCRNCCN Task Force report: update on the management of patients with gastrointestinal stromal tumorsJ Natl Compr Canc Netw20108Suppl 2S1S41 quiz S42–S44
   PubMed Web of Science ®Google Scholar
• LvALiZTianXSKP2 high expression, KIT exon 11 deletions, and gastrointestinal bleeding as predictors of poor prognosis in primary gastrointestinal stromal tumorsPLoS One20138e6295123690967
   PubMed Web of Science ®Google Scholar
• LiuQLiYDongMKongFDongQGastrointestinal bleeding is an independent risk factor for poor prognosis in GIST patientsBiomed Res Int20172017715240628589146
   PubMed Web of Science ®Google Scholar
• YinZGaoJLiuWClinicopathological and prognostic analysis of primary gastrointestinal stromal tumor presenting with gastrointestinal bleeding: a 10-year retrospective studyJ Gastrointest Surg20172179280028275959
   PubMed Web of Science ®Google Scholar
• ESMO / European Sarcoma Network Working GroupGastrointestinal stromal tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnn Oncol201223Suppl 7vii49vii5522997454
   PubMedGoogle Scholar
• GoldJSDematteoRPCombined surgical and molecular therapy: the gastrointestinal stromal tumor modelAnn Surg200624417618416858179
   PubMed Web of Science ®Google Scholar
• SircarKHewlettBRHuizingaJDChorneykoKBerezinIRiddellRHInterstitial cells of Cajal as precursors of gastrointestinal stromal tumorsAm J Surg Pathol19992337738910199467
   PubMed Web of Science ®Google Scholar
• CorlessCLSchroederAGriffithDPDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinibJ Clin Oncol2005235357536415928335
   PubMed Web of Science ®Google Scholar
• PantaleoMAAstolfiAIndioVSDHA loss-of-function mutations in KIT-PDGFRA wild-type gastrointestinal stromal tumors identified by massively parallel sequencingJ Natl Cancer Inst201110398398721505157
   PubMed Web of Science ®Google Scholar
• LimKTTanKYCurrent research and treatment for gastrointestinal stromal tumorsWorld J Gastroenterol2017234856486628785140
   PubMed Web of Science ®Google Scholar
• SøreideKSandvikOMSøreideJAGiljacaVJureckovaABulusuVRGlobal epidemiology of gastrointestinal stromal tumours (GIST): a systematic review of population-based cohort studiesCancer Epi-demiol2016403946
   PubMed Web of Science ®Google Scholar
• HeinrichMCOwzarKCorlessCLCorrelation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology GroupJ Clin Oncol2008265360536718955451
   PubMed Web of Science ®Google Scholar
• CorlessCLFletcherJAHeinrichMCBiology of gastrointestinal stromal tumorsJ Clin Oncol2004223813382515365079
   PubMed Web of Science ®Google Scholar
• Sarlomo-RikalaMKovatichAJBaruseviciusAMiettinenMCD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34Mod Pathol1998117287349720500
   PubMed Web of Science ®Google Scholar
• HirotaSIsozakiKMoriyamaYGain-of-function mutations of c-kit in human gastrointestinal stromal tumorsScience19982795775809438854
   PubMed Web of Science ®Google Scholar
• DeMatteoRPBallmanKVAntonescuCRLong-term results of adjuvant imatinib mesylate in localized, high-risk, primary gastrointestinal stromal tumor: ACOSOG Z9000 (Alliance) intergroup phase 2 trialAnn Surg201325842242923860199
   PubMed Web of Science ®Google Scholar
• MiettinenMLasotaJGastrointestinal stromal tumors–definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosisVirchows Arch200143811211213830
   PubMed Web of Science ®Google Scholar
• HoMYBlankeCDGastrointestinal stromal tumors: disease and treatment updateGastroenterology20111401372.e21376.e221420965
   PubMed Web of Science ®Google Scholar
• LasotaJMiettinenMClinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumoursHistopathol-ogy200853245266
   PubMed Web of Science ®Google Scholar
• HeinrichMCCorlessCLDuensingAPDGFRA activating mutations in gastrointestinal stromal tumorsScience200329970871012522257
   PubMed Web of Science ®Google Scholar
• IsozakiKHirotaSGain-of-function mutations of receptor tyrosine kinases in gastrointestinal stromal tumorsCurr Genomics2006746947518369405
   PubMed Web of Science ®Google Scholar
• ReichardtPHogendoornPCTamboriniEGastrointestinal stromal tumors I: pathology, pathobiology, primary therapy, and surgical issuesSemin Oncol20093629030119664490
   PubMed Web of Science ®Google Scholar
• Martín-BrotoJRubioLAlemanyRLópez-GuerreroJAClinical implications of KIT and PDGFRA genotyping in GISTClin Transl Oncol20101267067620947481
   PubMed Web of Science ®Google Scholar
• Ben-AmiEBarysauskasCMvon MehrenMLong-term follow-up results of the multicenter phase II trial of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of standard tyrosine kinase inhibitor therapyAnn Oncol2016271794179927371698
   PubMed Web of Science ®Google Scholar
• ParkSHRyuMHRyooBYSorafenib in patients with metastatic gastrointestinal stromal tumors who failed two or more prior tyrosine kinase inhibitors: a phase II study of Korean gastrointestinal stromal tumors study groupInvest New Drugs2012302377238322270258
   PubMed Web of Science ®Google Scholar
• DemetriGDCasaliPGBlayJYA phase I study of single-agent nilotinib or in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumorsClin Cancer Res2009155910591619723647
   PubMed Web of Science ®Google Scholar
• CorlessCLBallmanKVAntonescuCRPathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trialJ Clin Oncol2014321563157024638003
   PubMed Web of Science ®Google Scholar
• SleijferSSeynaeveCWiemerEVerweijJPractical aspects of managing gastrointestinal stromal tumorsClin Colorectal Cancer20066Suppl 1S18S2317101064
   PubMedGoogle Scholar
• SorourMAKassemMIGhazalAel-HEl-RiwiniMTAbu NasrAGastrointestinal stromal tumors (GIST) related emergenciesInt J Surg20141226928024530605
   PubMed Web of Science ®Google Scholar
• AjdukMMikulićDSebecićBSpontaneously ruptured gastrointestinal stromal tumor (GIST) of the jejunum mimicking acute appendicitisColl Antropol20042893794115666631
   PubMedGoogle Scholar
• CaterinoSLorenzonLPetruccianiNGastrointestinal stromal tumors: correlation between symptoms at presentation, tumor location and prognostic factors in 47 consecutive patientsWorld J Surg Oncol201191321284869
   PubMed Web of Science ®Google Scholar
• BaMCQingSHHuangXCWenYLiGXYuJDiagnosis and treatment of small intestinal bleeding: retrospective analysis of 76 casesWorld J Gastroenterol2006127371737417143959
   PubMed Web of Science ®Google Scholar
• BlanchardDKBuddeJMHatchGFTumors of the small intestineWorld J Surg20002442142910706914
   PubMed Web of Science ®Google Scholar
• HwangJHSaundersMDRulyakSJShawSNietschHKimmeyMBA prospective study comparing endoscopy and EUS in the evaluation of GI subepithelial massesGastrointest Endosc20056220220816046979
   PubMed Web of Science ®Google Scholar
• NaHKLeeJHParkYSYields and utility of endoscopic ultrasonography-guided 19-gauge trucut biopsy versus 22-gauge fine needle aspiration for diagnosing gastric subepithelial tumorsClin Endosc20154815215725844344
   PubMed Web of Science ®Google Scholar
• KobayashiKGuptaSTrentJCHepatic artery chemoembolization for 110 gastrointestinal stromal tumors: response, survival, and prognostic factorsCancer20061072833284117096432
   PubMed Web of Science ®Google Scholar
• Van den AbbeeleADThe lessons of GIST–PET and PET/CT: a new paradigm for imagingOncologist200813Suppl 281318434632
   PubMed Web of Science ®Google Scholar
• GayedIVuTIyerRThe role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumorsJ Nucl Med2004451172114734662
   PubMed Web of Science ®Google Scholar
• TanYTanLLuJEndoscopic resection of gastric gastrointestinal stromal tumorsTransl Gastroenterol Hepatol2017211529354772
   PubMedGoogle Scholar
• PiessenGLefèvreJHCabauMLaparoscopic versus open surgery for gastric gastrointestinal stromal tumors: what is the impact on postoperative outcome and oncologic results?Ann Surg2015262831839 discussion 829–84026583673
   PubMed Web of Science ®Google Scholar
• NovitskyYWKercherKWSingRFLong-term outcomes of laparoscopic resection of gastric gastrointestinal stromal tumorsAnn Surg2006243738745 discussion 745–74716772777
   PubMed Web of Science ®Google Scholar
• KeungEZRautCPManagement of gastrointestinal stromal tumorsSurg Clin North Am20179743745228325196
   PubMed Web of Science ®Google Scholar
• NishidaTBlayJYHirotaSKitagawaYKangYKThe standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelinesGastric Cancer20161931426276366
   PubMed Web of Science ®Google Scholar
• ZhiXJiangBYuJPrognostic role of microscopically positive margins for primary gastrointestinal stromal tumors: a systematic review and meta-analysisSci Rep201662154126891953
   PubMed Web of Science ®Google Scholar
• McCarterMDAntonescuCRBallmanKVMicroscopically positive margins for primary gastrointestinal stromal tumors: analysis of risk factors and tumor recurrenceJ Am Coll Surg20122155359 discussion 59–6022726733
   PubMed Web of Science ®Google Scholar
• QuekRGeorgeSGastrointestinal stromal tumor: a clinical overviewHematol Oncol Clin North Am200923697819248971
   PubMed Web of Science ®Google Scholar
• DeMatteoRPLewisJJLeungDMudanSSWoodruffJMBrennanMFTwo hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survivalAnn Surg2000231515810636102
   PubMed Web of Science ®Google Scholar
• ESMO/European Sarcoma Network Working GroupGastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnn Oncol201425Suppl 3iii21iii2625210085
   PubMed Web of Science ®Google Scholar
• JoensuuHMartin-BrotoJNishidaTReichardtPSchöffskiPMakiRGFollow-up strategies for patients with gastrointestinal stromal tumour treated with or without adjuvant imatinib after surgeryEur J Cancer2015511611161726022432
   PubMedGoogle Scholar
• KeungEZFairweatherMRautCPThe role of surgery in metastatic gastrointestinal stromal tumorsCurr Treat Options Oncol201617826820287
   PubMed Web of Science ®Google Scholar
• VadakaraJvon MehrenMGastrointestinal stromal tumors: management of metastatic disease and emerging therapiesHematol Oncol Clin North Am20132790592024093167
   PubMed Web of Science ®Google Scholar
• von MehrenMGastrointestinal stromal tumorsJ Clin Oncol20183613614329220298
   PubMed Web of Science ®Google Scholar
• CasaliPGZalcbergJLe CesneATen-year progression-free and overall survival in patients with unresectable or metastatic GI stromal tumors: long-term analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III randomized trial on imatinib at two dose levelsJ Clin Oncol2017351713172028362562
   PubMed Web of Science ®Google Scholar
• BlankeCDRankinCDemetriGDPhase III randomized, inter-group trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033J Clin Oncol20082662663218235122
   PubMed Web of Science ®Google Scholar
• Debiec-RychterMSciotRLe CesneAKIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumoursEur J Cancer20064281093110316624552
   PubMed Web of Science ®Google Scholar
• DemetriGDvan OosteromATGarrettCREfficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trialLancet20063681329133817046465
   PubMed Web of Science ®Google Scholar
• BlayJYLe CesneARay-CoquardIProspective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma GroupJ Clin Oncol2007251107111317369574
   PubMed Web of Science ®Google Scholar
• Le CesneARay-CoquardIBuiBNDiscontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trialLancet Oncol20101194294920864406
   PubMed Web of Science ®Google Scholar
• HallerFDetkenSSchultenHJSurgical management after neo-adjuvant imatinib therapy in gastrointestinal stromal tumours (GISTs) with respect to imatinib resistance caused by secondary KIT mutationsAnn Surg Oncol20071452653217139461
   PubMed Web of Science ®Google Scholar
• GeorgeSBlayJYCasaliPGClinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumour after imatinib failureEur J Cancer2009451959196819282169
   PubMed Web of Science ®Google Scholar
• RubinBPBlankeCDDemetriGDProtocol for the examination of specimens from patients with gastrointestinal stromal tumorArch Pathol Lab Med201013416517020121601
   PubMed Web of Science ®Google Scholar
• JagoditschMPozgainerPKlinglerATschmelitschJImpact of blood transfusions on recurrence and survival after rectal cancer surgeryDis Colon Rectum2006491116113016779711
   PubMed Web of Science ®Google Scholar
• DharDKKubotaHTachibanaMLong-term survival of trans-mural advanced gastric carcinoma following curative resection: multivariate analysis of prognostic factorsWorld J Surg200024588593 discussion 593–59410787082
   PubMed Web of Science ®Google Scholar
• FernandezPMPatiernoSRRicklesFRTissue factor and fibrin in tumor angiogenesisSemin Thromb Hemost2004303144
   PubMed Web of Science ®Google Scholar
• AoyagiKKouhujiKYanoSVEGF significance in peritoneal recurrence from gastric cancerGastric Cancer2005815516316086118
   PubMedGoogle Scholar
• SteigenSEBjerkehagenBHauglandHKDiagnostic and prognostic markers for gastrointestinal stromal tumors in NorwayMod Pathol200821465317917670
   PubMed Web of Science ®Google Scholar
• MinhajatRMoriDYamasakiFSugitaYSatohTTokunagaOOrgan-specific endoglin (CD105) expression in the angiogenesis of human cancersPathol Int20065671772317096728
   PubMed Web of Science ®Google Scholar
• ParkSSRyuJSOhSYKimWBLeeJHChaeYSSurgical outcomes and immunohistochemical features for gastrointestinal stromal tumors (GISTS) of the stomach: with special reference to prognostic factorsHepatogastroenterology2007541454145717708275
   PubMedGoogle Scholar
• MajerIMGelderblomHvan den HoutWBCost-effectiveness of 3-year vs 1-year adjuvant therapy with imatinib in patients with high risk of gastrointestinal stromal tumour recurrence in the Netherlands; a modelling study alongside the SSGXVIII/AIO trialJ Med Econ2013161106111923808902
   PubMedGoogle Scholar
• PatrikidouAKey messages from the BFR14 trial of the French Sarcoma GroupFuture Oncol20171327328427624671
   PubMed Web of Science ®Google Scholar
• KangYKRyuMHYooCResumption of imatinib to control metastatic or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib (RIGHT): a randomised, placebo-controlled, phase 3 trialLancet Oncol2013141175118224140183
   PubMed Web of Science ®Google Scholar
• CasaliPGLe CesneAPoveda VelascoATime to definitive failure to the first tyrosine kinase inhibitor in localized GI stromal tumors treated with imatinib as an adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in collaboration with the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on SarcomasJ Clin Oncol2015334276428326573069
   PubMed Web of Science ®Google Scholar
• MiettinenMSobinLHGastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-upAm J Surg Pathol200529526815613856
   PubMed Web of Science ®Google Scholar
• Risk stratification of patients diagnosed with gastrointestinal stromal tumorHum Pathol2008391411141918774375
   PubMed Web of Science ®Google Scholar